Skip to main content

Table 1 Baseline characteristics of normokalemic (control) and hyperkalemic patients

From: ECG alterations suggestive of hyperkalemia in normokalemic versus hyperkalemic patients

 

Age (years)

 

Female

Prior CKD

Prior RRT

Death within 72 h

need of RRT

HF

DM

HT

Liver failure

Sepsis

Malignancy

Dehydration

B-blocker

Digitalis

ACEi

ARB

Spironolactone

Amilorid

NSAID

K suppl

Kontroll (n = 170)

60.45 ± 15.95

%

54,7%

8,8%

1,2%

2,4%

0,0%

11,8%

20,6%

64,1%

4,1%

1,2%

14,1%

10,0%

38,8%

4,1%

37,6%

10,6%

4,7%

1,2%

8,2%

15,3%

n

93

15

2

4

0

20

35

109

7

2

24

17

66

7

64

18

8

2

14

26

Hyper-kalemia (n = 135)

70.61 ± 13.93

%

51,9%

29,6%*

7,4%*

13,3%*

15,6%*

32,6%*

36,3%*

73,3%

11,1%*

14,8%*

29,6%*

31,1%*

45,9%*

5,9%

54,8%*

14,1%*

15,6%*

14,1%*

16,3%*

35,6%*

n

70

40

10

18

21

44

49

99

15

20

40

42

62

8

74

19

21

19

22

48

  1. (CKD: chronic kidney disease, RRT renal replacment therapy, HF: heart failure, DM: diabetes mellitus, HT: hypertension, K suppl: potassium supplementation, *: p ≤ 0,05)